NOVA LEAP HEALTH CORP (NLH.CA) Stock Analyst Earnings Estimates
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 21.279M 22.93% | 28.205M 32.55% | 26.179M -7.18% | 27.501M 5.05% | |
| EBITDA YoY % growth | -369.92K -349.69% | 293.8K 179.42% | 1.345M 357.89% | 1.854M 37.82% | |
| EBIT YoY % growth | -1.231M -210.90% | -1.062M 13.75% | 460.16K 143.32% | 5.665B 1,230,993.53% | |
| Operating Margin | -5.79% | -3.77% | 1.76% | 20,599.25% | |
| EPS YoY % growth | 0.04 | -0.01 -121.62% | -0.01 -12.50% | 0.01 214.44% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | 0.00 100.00% |
| Revenue Q2Q % growth | 7.313M -18.01% |
| EBITDA Q2Q % growth | 515K -57.19% |
| EBIT Q2Q % growth | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 0.00 | % | |
| Q1 2024 Q2Q % growth | 0.01 266.67% | 0.00 | 0.01 | % |
| Q4 2023 Q2Q % growth | -0.01 | 0.00 | -0.01 | % |
| Q3 2023 Q2Q % growth | 0.00 -42.86% | 0.00 | 0.00 | % |
| Q1 2023 Q2Q % growth | 0.00 40.00% | 0.00 | 0.00 | % |
| Q4 2022 Q2Q % growth | -0.01 23.08% | 0.03 | -0.04 | -138.04% |
| Q3 2022 Q2Q % growth | 0.01 -72.00% | 0.00 | 0.01 | % |
| Q2 2022 Q2Q % growth | 0.00 -100.00% | 0.01 | -0.01 | -100.00% |
| Q1 2022 Q2Q % growth | -0.01 -138.46% | 0.00 | -0.01 | % |
| Q4 2021 Q2Q % growth | -0.01 | 0.02 | -0.03 | -163.11% |
| Q2 2021 Q2Q % growth | 0.01 | 0.00 | 0.01 | 482.52% |
| Q1 2021 Q2Q % growth | 0.01 | 0.00 | 0.01 | 1,362.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.407M -2.25% | 6.798M | -391.47K | -5.76% |
| Q2 2024 Q2Q % growth | 6.339M -5.07% | 9.148M | -2.809M | -30.71% |
| Q1 2024 Q2Q % growth | 6.43M 0.53% | 8.871M | -2.441M | -27.52% |
| Q4 2023 Q2Q % growth | 8.919M 31.55% | 12.087M | -3.168M | -26.21% |
| Q3 2023 Q2Q % growth | 6.554M -8.23% | 10.036M | -3.482M | -34.70% |
| Q2 2023 Q2Q % growth | 6.677M -4.43% | 9.211M | -2.534M | -27.51% |
| Q1 2023 Q2Q % growth | 6.396M -12.34% | 9.242M | -2.846M | -30.79% |
| Q4 2022 Q2Q % growth | 6.78M 14.72% | 9.332M | -2.552M | -27.35% |
| Q3 2022 Q2Q % growth | 7.142M 35.69% | 9.201M | -2.059M | -22.38% |
| Q2 2022 Q2Q % growth | 6.987M 37.39% | 9.947M | -2.96M | -29.76% |
| Q1 2022 Q2Q % growth | 7.297M 45.35% | 9.309M | -2.012M | -21.62% |
| Q4 2021 Q2Q % growth | 5.91M 31.82% | 7.377M | -1.467M | -19.88% |
| Q3 2021 Q2Q % growth | 5.263M 24.39% | 6.18M | -916.76K | -14.83% |
| Q2 2021 Q2Q % growth | 5.085M 27.67% | 5.665M | -579.55K | -10.23% |
| Q1 2021 Q2Q % growth | 5.02M 8.87% | 5.253M | -232.86K | -4.43% |
| Q4 2020 Q2Q % growth | 4.484M -6.96% | % | ||
| Q3 2020 Q2Q % growth | 4.231M -4.36% | % | ||
| Q2 2020 Q2Q % growth | 3.983M -6.27% | % | ||
| Q1 2020 Q2Q % growth | 4.611M 17.88% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | 0% | -39.36% | 0% | 0% |